HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A placebo-controlled trial of oral ergometrine to reduce postpartum hemorrhage.

AbstractBACKGROUND:
Active management with oral ergometrine 0.4 mg was compared with expectant management for the control of blood loss in the third stage of labor in women at low risk of postpartum hemorrhage (PPH).
METHODS:
A three-arms randomized trial in which 0.4 mg ergometrine (2 tablets of 0.2 mg) was set off against placebo, both groups allowing comparison with a standard oxytocin regimen of 5 IU. Women at low risk for PPH. Of 367 parturients, 146 were randomised to ergometrine 0.4 mg, 143 to placebo and 78 to intramuscular oxytocin in a 2:2:1 design.
RESULTS:
Compared with placebo, ergometrine reduced blood loss with 5% (-5%; Confidence interval: -20% to +13%). Oxytocin reduced blood loss with 9% (-9%; Confidence interval: -26% to +12%) versus placebo.
CONCLUSION:
Oral ergometrine has too little effect on blood loss after childbirth in order to be a good alternative to parenteral prophylactic management.
AuthorsA N de Groot, J van Roosmalen, P W van Dongen, G F Borm
JournalActa obstetricia et gynecologica Scandinavica (Acta Obstet Gynecol Scand) Vol. 75 Issue 5 Pg. 464-8 (May 1996) ISSN: 0001-6349 [Print] United States
PMID8677772 (Publication Type: Clinical Trial, Clinical Trial, Phase II, Journal Article, Randomized Controlled Trial)
Chemical References
  • Placebos
  • Ergonovine
Topics
  • Administration, Oral
  • Adult
  • Ergonovine (administration & dosage, therapeutic use)
  • Female
  • Humans
  • Parity
  • Placebos
  • Postpartum Hemorrhage (drug therapy, prevention & control)
  • Pregnancy
  • Pregnancy Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: